REFERENCES

1.  United Nations Office on Drugs and Crime. World Drug Report 2010 (United Nations publication, sales no. E.10.XI.13). 2010.

2.  Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009; 374(9698): 1383-91.

3.  McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W. Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. International Journal of Drug Policy. 2010; 21(1): 10-9.

4.  Tan WC, Lo C, Jong A, Xing L, FitzGerald MJ, Vollmer WM, et al. Marijuana and chronic obstructive lung disease: a population-based study. Canadian Medical Association Journal. 2009; 180(8): 814.

5.  Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J, et al. Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacology, Biochemistry, and Behavior. 2010; 96(3): 333-41.

6.  Hall W. The adverse health effects of cannabis use: what are they, and what are their implications for policy? International Journal of Drug Policy. 2009; 20(6): 458-66.

7.  Taylor DR, Poulton R, Moffitt TE, Ramankutty P, Sears MR. The respiratory effects of cannabis dependence in young adults. Addiction. 2000; 95(11): 1669-77.

8.  Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007; 62(12): 1058-63. Erratum in: Thorax. 2008; 63(4): 385.

9.  Han B, Gfroerer JC, Colliver JD. Associations between duration of illicit drug use and health conditions: results from the 2005–2007 national surveys on drug use and health. Annals of Epidemiology. 2010; 20(4): 289-97.

10.  Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007; 370(9584): 319-28.

11.  Cheung JTW, Mann RE, Ialomiteanu A, Stoduto G, Chan V, Ala-Leppilampi K, et al. Anxiety and mood disorders and cannabis use. American Journal of Drug and Alcohol Abuse. 2010; 36(2): 118-22.

12.  Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007; 369(9566): 1047-53.

13.  Ellingwood K. Mexico death toll in drug war higher than previously reported. Los Angeles Times. April 14, 2010.

14.  Castaneda JG. What’s Spanish for quagmire? Five myths that caused the failed war next door. Foreign Policy. Jan/Feb 2010. http://www.foreignpolicy.com/articles/2010/01/04/whats_spanish_for_quagmire

15.  Royal Canadian Mounted Police. Drug Situation in Canada 1998–2003. http://www.rcmp-grc.gc.ca/drugs-drogues/index-eng.htm.

16.  Library of Congress. Marijuana availability in the United States and its associated territories. http://www.loc.gov/rr/frd/pdf-files/MarAvail.pdf.

17.  United States Government Accountability Office. Contractor’s national evaluation did not find that the youth anti-drug media campaign was effective in reducing youth drug use. http://www.gao.gov/new.items/d06818.pdf.

18.  Fishbein M, Hall-Jamieson K, Zimmer E, von Haeften I, Nabi R. Avoiding the boomerang: testing the relative effectiveness of antidrug public service announcements before a national campaign. American Journal of Public Health. 2002; 92(2): 238-45.

19.  West SL, O’Neal KK. Project D.A.R.E. outcome effectiveness revisited. American Journal of Public Health. 2004; 94(6): 1027-9.

20.  Borland S. Legalize heroin and cocaine to cut crime and improve health, top doctor says. Daily Mail. August 17, 2010.

21.  Wood E, Werb D, Kazatchkine M, Kerr T, Hankins C, Gorna R, et al. Vienna Declaration: a call for evidence-based drug policies. Lancet. 2010; 376(9738): 310-2.

22.  Kilmer B, Caulkins JP, Pacula RL, MacCoun R, Reuter PH. Altered state? Assessing how marijuana legalization in California could influence marijuana consumption and public budgets. Santa Monica: RAND Corporation; 2010.

23.  US National Institutes on Drug Abuse. Quarterly Report. Potency Monitoring Project Report 104. December 16, 2008 thru March 15, 2009. http://www.whitehousedrugpolicy.gov/publications/pdf/mpmp_report_104.pdf.

24.  Institute for Defence Analysis. The price and purity of illicit drugs: 1981–2007. http://www.whitehousedrugpolicy.gov/publications/price_purity/price_purity07.pdf.

25.  Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future: national survey results on drug use, 1975-2005. Volume I. Secondary school students (NIH publication no. 06-5883). Bethesda, MD: National Institute on Drug Abuse.

26.  Office of Applied Studies. Results from the 2002 national survey on drug use and health: national findings (DHHS publication no. SMA 03–3836, NHSDA series H–22). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2003. http://www.oas.samhsa.gov/2k4/MJsource/MJsource.htm.

27.  Monitoring the future: a continuing study of American youth. http://monitoringthefuture.org/data/data.html.

28.  MacCoun R, Reuter P. Evaluating alternative cannabis regimes. British Journal of Psychiatry. 2001; 178(2): 123.

29.  Levine HG, Gettman JB, Siegel L. Targeting blacks for marijuana: possession arrests of African Americans in California, 2004–2008. Drug Policy Alliance, LA. June 2010.

30.  Miron JA. The budgetary implications of marijuana prohibition. Cambridge: Harvard University; 2008.

31.  World Drug Report 2005. Vienna: United Nations Office on Drugs and Crime; 2005.

32.  Thoumi FE. Illegal drugs, economy, and society in the Andes. Washington, DC: Woodrow Wilson Center Press; 2003.

33.  Tuckman J. Mexico looks to legalization as drug war murders hit 28,000. The Guardian. August 4, 2010. http://www.guardian.co.uk/world/2010/aug/04/mexico-legalisation-debate-drug-war.

34.  Office of National Drug Control Policy. ONDCP statement on Mexican drug trafficking organization profits from marijuana. http://www.ondcp.gov/news/press10/MJrevenue.pdf.

35.  Werb D, Rowell G, Guyatt G, Kerr T, Montaner J, Wood E. Effect of drug law enforcement on drug related violence: evidence from a scientific review. Vancouver: International Centre for Science in Drug Policy; 2010.

36.  Diebel L. How Mexico’s drug war washed up on Canada’s West Coast. Toronto Star. March 4, 2009.

37.  United States Department of Health and Human Services, Office of Applied Studies. National survey on drug use and health, 2002–2007.

38.  Administration UDE. Fact 6: Legalization of drugs will lead to increased use and increased levels of addiction. Legalization has been tried before, and failed miserably.

39.  Korf DJ. Dutch coffee shops and trends in cannabis use. Addictive Behaviors. 2002; 27(6): 851-66.

40.  Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Medicine. 2008; 5(7): e141.

41.  Basov S, Jacobson M, Miron JA. Prohibition and the market for illegal drugs. World Economics. 2001; 2(4): 133-57.

42.  Simons-Morton B, Pickett W, Boyce W, ter Bogt TFM, Vollebergh W. Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada, and the Netherlands. International Journal of Drug Policy. 2010; 21(1): 64-9.

43.  van den Brink W. Forum: Decriminalization of cannabis. Current Opinion in Psychiatry. 2008; 21(2): 122-6.

44.  Hughes C, Stevens A. What can we learn from the Portuguese decriminalization of illicit drugs? British Journal of Criminology. http://bjc.oxfordjournals.org/content/early/2010/07/21/bjc.azq038.

45.  Vale de Andrade P, Carapinha L. Drug decriminalisation in Portugal. British Medical Journal. 2010; 341: c4554.

46.  Rolles S. After the war on drugs: blueprint for regulation. Transform Drug Policy Foundation. 2009.

47.  Kilmer B, Caulkins JP, Pacula RL, MacCoun RJ, Reuter PH. Altered state? Assessing how marijuana legalization in California could influence marijuana consumption and public budgets. RAND Drug Policy Research Centre. 2009.

48.  Reuter P. Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals. Addiction. 2009; 104(4): 510-7.

49.  Room R, Fischer B, Hall W, Lenton S, Reuter P. Cannabis policy: moving beyond stalemate. Oxford: Oxford University Press; 2010.

50.  Room R. In thinking about cannabis policy, what can be learned from alcohol and tobacco? In: A cannabis reader: global issues and local experiences, Monograph series 8, Volume 1, European Monitoring Centre for Drugs and Drug Addiction, Lisbon. 2008.

51.  Lewit E, Hyland A, Kerrebrock N, Cummings K. Price, public policy, and smoking in young people. Tobacco Control. 1997; 6 Suppl 2: S1724.

52.  Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005; 365: 519-30.

53.  Anderson P, De Bruijn A, Angus K, Gordon R, Hastings G. Impact of alcohol advertising and media exposure on adolescent alcohol use: a systematic review of longitudinal studies. Alcohol and Alcoholism. 2009; 44(3): 229-43.

54.  Emont S, Choi W, Novotny T, Giovino G. Clean indoor air legislation, taxation and smoking behaviour in the United States: an ecological analysis. Tobacco Control. 1992;2: 13-7.

55.  Levy D, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. Journal of Public Health Management and Practice. 2004; 10(4): 338-53.

56.  Wellman RJ, Sugarman DB, DiFranza JR, Winickoff JP. The extent to which tobacco marketing and tobacco use in films contribute to children’s use of tobacco: a meta-analysis. Archives of Pediatrics & Adolescent Medicine. 2006; 160(12): 1285-96.

57.  Schwarzenegger welcomes debate over legalizing pot. Reuters News. May 6, 2008. http://www.reuters.com/article/idUSTRE54503R20090506.

58.  US Government Accountability Office. B-30349. January 4, 2005. http://www.gao.gov/decisions/appro/303495.htm.

59.  Levitt SD, Venkatesh SA. An economic analysis of a drug-selling gang’s finances. Quarterly Journal of Economics. 2000; 115(3): 755-89.

60.  Ingenito R. Prepared testimony of Robert Ingenito. Sacramento: California State Board of Equalization; 2009.

61.  Anderson PW, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009; 373(9682): 2234-46.

62.  Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL. Vaporization as a smokeless cannabis delivery system: a pilot study. Clinical Pharmacology and Therapeutics. 2007; 82(5): 572-8.

63.  Van Dam NT, Earleywine M. Pulmonary function in cannabis users: support for a clinical trial of the vaporizer. International Journal of Drug Policy. 2010 May 5 [Epub ahead of print].